ArticleBiomedicines2024

Comparing the Efficacy of Two Generations of EGFR-TKIs: An Integrated Drug-Disease Mechanistic Model Approach in EGFR-Mutated Lung Adenocarcinoma.

Hippolyte Darré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.